Cargando…
Micromolar affinity CAR T cells to ICAM-1 achieves rapid tumor elimination while avoiding systemic toxicity
Adoptive transfer of high-affinity chimeric antigen receptor (CAR) T cells targeting hematological cancers has yielded impressive clinical results. However, safety concerns regarding target expression on healthy tissue and poor efficacy have hampered application to solid tumors. Here, a panel of aff...
Autores principales: | Park, Spencer, Shevlin, Enda, Vedvyas, Yogindra, Zaman, Marjan, Park, Susan, Hsu, Yen-Michael S., Min, Irene M., Jin, Moonsoo M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5662687/ https://www.ncbi.nlm.nih.gov/pubmed/29085043 http://dx.doi.org/10.1038/s41598-017-14749-3 |
Ejemplares similares
-
SSTR2 as an anatomical imaging marker and a safety switch to monitor and manage CAR T cell toxicity
por: Alcaina, Yago, et al.
Publicado: (2022) -
Manufacturing and preclinical validation of CAR T cells targeting ICAM-1 for advanced thyroid cancer therapy
por: Vedvyas, Yogindra, et al.
Publicado: (2019) -
Publisher Correction: Manufacturing and preclinical validation of CAR T cells targeting ICAM-1 for advanced thyroid cancer therapy
por: Vedvyas, Yogindra, et al.
Publicado: (2020) -
Chimeric Antigen Receptor T Cell Therapy Targeting ICAM-1 in Gastric Cancer
por: Jung, Minkyu, et al.
Publicado: (2020) -
General Anesthetics Predicted to Block the GLIC Pore with Micromolar Affinity
por: LeBard, David N., et al.
Publicado: (2012)